Sanofi, GSK plc and CSL Limited
GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract (update)
EST: Adds comments from CSL The U.S. has reportedly awarded $72M to GSK (NYSE:GSK), Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY) to expand the production of bird flu vaccines amid an ongoing outbreak among poultry and livestock that has led to fears of a potential human-to-human transmission of the virus.
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising the country’s total supply of ready-to-use doses to 10 million within the f
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
The U.S. government collaborates with GSK, Sanofi, and CSL to enhance bird flu vaccine production. This initiative aims to increase vaccine readiness to 10 million doses by early 2025 amid rising H5 cases.
GSK, Sanofi, CSL nab $72M in BARDA funding to boost bird flu vaccine supply
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. | CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.
US provides $72M to vaccine manufacturers to advance bird flu shot preparedness
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is being done out of "an abundance of caution."
The US Is Loading Up on Bird Flu Vaccine
As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its vaccine stockpile.
BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to help fortify the US supply of bird flu vaccine ahead of 2025. The funding was disclosed by the Administration for Strategic Preparedness and Response,
How effective is the flu shot this year? New report reveals 'disappointing' data
The 2018-2019 influenza season is one such case. The vaccine’s effectiveness during that year was an abysmal 29%, according ...
scrippsnews on MSN2d
Harnessing Your Health: What you need to know about COVID-19, flu, and RSV for the fall and winter
There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...